Requesting a Call: +91 98100 70969

Team Details

Siddharth Manvati

Technical Resource

Current Publication Status (Ref: Research Gate):

Research Publications Online: 15               Total Citations: 240                                                                         

Total Impact Factor: 51.78

 Current Status:

  • Assisting in creation of NABL Accredited labs,
  • QMS Medical devices, Additional Essential Principles for NON IVD & IVD Medical Devices IS 23945 – Trainer
  • Assisting Startups : Foresight Biotech Pvt build their R&D Department.
  • “UGC-Ds Kothari Post Doc Fellow” at School of Biotechnology, Jawaharlal Nehru University, New Delhi. (2015 Onwards)
  • Engaged in experimental assistance for various projects at School of Biotechnology and School of Life Sciences, Jawaharlal Nehru University, New Delhi.
  •  Part of “1st – iBEC (Indian Biological Engineering Competition – 2016)” Organising committee.
  •  Part of “1st – iBEM (Indian Biological Engineering Meeting – 2017)” Organising committee.

 Key Skills:

  •   Project Writing and Management (DBT / DST / ICMR / CSIR and Many More)
  •   Networking & Positive Interaction / approach
  •   Skill / Manpower Management & Development as per requirements
  •   Financial Assessment of available resources

 Academic Qualifications:

  • Phd in Biotechnology (2010-2015) under the supervision of Padamshree Prof. R.N.K.Bamezai, from Shri Mata Vaishnov Devi University Katra, J&K.
  • Master of Science in Molecular & Human Genetics from Jiwaji University, Gwalior (2006-2008) with 72%.
  • Bachelor of Science in Biotechnology from, Pad. Dr.D.Y.Patil Arts Commerce & Science College, Pimpri, Pune, University Of Pune, Pune, Maharashtra in 2006, with 62%.
  • Senior Secondary in PCB from Delhi Public School, CBSE Board in 2003, with 66.4%.
  •  Secondary Examination from Delhi Public School, CBSE Board in 2001 with 71%.

 Research Publications

  • Manvati S, Mangalhara K, Khan J, Pathania G, Kaul S, Kaushik M, Arora A, Dhar PK. “Deciphering the role of microRNA – A step by step guide”. Gene Expression Patterns 2017, PMID: 28603023.
  • Chandra Mangalhara K, Manvati S, Saini SK, Ponnusamy K, Agarwal G, Abraham SK, Bamezai RN. “ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer.” Cancer Lett. 2017, PMID: 28109909.
  •  Manvati S, Mangalhara K, Kalaiarasan P, Bamezai RNK. (2015) “Mir-145 over expression results in Epithelial to Mesenchymal transition in MCF7 cells” Oncotarget 2016, PMID : Pending.
  • Manvati S, Mangalhara K, Kalaiarasan P, Srivastava N, Bamezai RNK . “miR- 24-2 regulates genes in survival pathway and demonstrates potential in reducing cellular viability in combination with docetaxel”. Gene, 2015, PMID: 25943634.
  • Pandita A, Manvati S, Singh SK, Vaishnavi S, Bamezai RN. “Combined effect of microRNA, nutraceuticals and drug on pancreatic cancer cell lines” Chem Biol Interact, 2015, PMID: 25841339
  •  Manvati S, Mangalhara K, Kalaiarasan P, Srivastava N, Kumar B, Bamezai RNK .(2014) “miR-101 induces senescence and prevents apoptosis in the background of DNA damage in MCF7 cells”. PloS One, 2014, PMID: 25353636.
  • Singh K R, Srivastava A, Kalaiarasan P, Manvati S, Chopra R, Bamezai R N K “mtDNA germ line variation mediated ROS generates retrograde signaling and induces pro-cancerous metabolic features.” Nature Scientific Reports, 2014, PMID: 25300428.
  • Pandita A, Kumar B, Manvati S, Vaishnavi S, Singh K S, Bamezai R N K “Synergistic combination of gemcitabine and dietary molecule(s) induces apoptosis in pancreatic cancer cells & down regulates PKM2 expression”. PloS One, 2014, PMID: 25197966.